Strategic Partnership ISB is a non-profit biomedical research organization affiliated with Providence, offering potential for collaboration with healthcare networks, clinical data access, and translational projects that align with payer and hospital systems seeking cutting-edge research integration.

Biosecurity & COVID ISB has active engagements in infectious disease research including COVID and collaboration history with Merck on SARS-CoV-2 molecular activity, indicating opportunities in vaccine, antiviral, and diagnostic partnerships or funded research programs.

Cancer Collaboration Recent collaboration with NED Biosystems to address cancer onset suggests opportunities in oncology research tools, biomarker development, and translational studies that could attract pharma or biotech collaborators.

Tech & Data ISB operates with a modern tech stack and digital presence; potential to offer data analytics, bioinformatics, and software-enabled research platforms to accelerate translational science for industry partners and contract research.

Scale & Funding With a revenue range of 100–250 million and funding around 13 million, ISB represents a mid-to-large research partner capable of multi-year collaborations, core facilities access, and consortium-style grant opportunities for industry sponsorships.